Icon

DUONEB (nda020950)- (EQ 0.083% BASE;0.017%)

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE NORVIUM BIOSCIENCE
EQ 0.083% BASE;0.017%
Yes Yes
2021-Dec-28 Expired
None None
None No
DuoNeb is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator.
4 0 4
Total Other Developers None
Drugs with Suitability Yes
EQ 0.083% BASE;0.017% ** ** - - 4
NDA Sales Available Total Generic Sales Available
No 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ******* ** ***. *********** **** **** ****** *********, **** ********, ***** ******** (**) *****, ****** ****** (***) ***
****** ***** ***** ******* *********** **** ** ****, *-*** ** *-***, *-*** ** *-***, **** ** *-***/*/*/*, *-****, *-***, *-***, *-***, ***** ********** ****, ********, *** ******, ***** (***) ***
****** ***** ***** ******* *********** **** **. * &** ****** ******* ******** ****, ***** **, ********* ****, ****** ******* ******, ***** (***) ***
****** ******** **** *** ******** *********** *********** * ********** ******, ********, ***** ******** (**) *****, ****** ****** (***) ***
****** *** ***** *** ************** ******** ******* *********** ****** **. ** *** ** - ******* :- ***** **** - *****, ***** **********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.